A case of acute cholestatic jaundice after hormone treatment of Graves disease with upper respiratory tract infection
10.3760/cma.j.cn101721-20220629-000275
- VernacularTitle:激素治疗Graves病合并上呼吸道感染后发生急性胆汁淤积性黄疸1例
- Author:
Baotian XIA
1
;
Hongcui DIAO
;
Shuguang PANG
Author Information
1. 潍坊医学院临床医学院，潍坊 261053
- Keywords:
Graves' disease;
Upper respiratory tract infection;
Cholestatic jaundice;
Glucocorticoid hormone
- From:
Clinical Medicine of China
2023;39(1):61-63
- CountryChina
- Language:Chinese
-
Abstract:
Cholestatic jaundice is rare in patients with Graves' disease and is generally considered to be a complication of Graves' disease or an adverse reaction to methimazole. We report a case of acute cholestatic jaundice caused by Graves' disease complicated with upper respiratory tract infection in Jinan Central Hospital. After timely treatment with glucocorticoid, the jaundice quickly subsided and the liver function gradually returned to normal. We believe that Graves' disease combined with upper respiratory tract infection can lead to cholestatic jaundice, the pathogenesis of which may be immune dysfunction, and glucocorticoid therapy is beneficial to the regression of jaundice.
